ClinicalTrials.gov record
Efficacy and Safety of Toujeo® Versus Tresiba® in Insulin-Naive Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Oral Antihyperglycemic Drug(s) ± GLP-1 Receptor Agonist
ClinicalTrials.gov ID: NCT02738151
Public ClinicalTrials.gov record NCT02738151. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 24-week, Multicenter, Randomized, Open-Label, Parallel-group StudyComparing the Efficacy and Safety of Toujeo® and Tresiba® in Insulin-NaivePatients With Type 2 Diabetes Mellitus Not Adequately Controlled With OralAntihyperglycemic Drug(s) ± GLP-1 Receptor Agonist
Study identification
- NCT ID
- NCT02738151
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Sanofi
- Industry
- Enrollment
- 929 participants
Conditions and interventions
Conditions
Interventions
- Insulin degludec, 100 U/mL Drug
- Insulin glargine, 300U/mL Drug
- Non-insulin anti-diabetic treatment Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 18, 2016
- Primary completion
- Aug 14, 2017
- Completion
- Aug 14, 2017
- Last update posted
- Sep 13, 2018
2016 – 2017
United States locations
- U.S. sites
- 74
- U.S. states
- 24
- U.S. cities
- 65
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site Number 840038 | Sheffield | Alabama | 35660 | — |
| Investigational Site Number 840066 | Phoenix | Arizona | 85020 | — |
| Investigational Site Number 840051 | Anaheim | California | 92801 | — |
| Investigational Site Number 840081 | Chino | California | 91710 | — |
| Investigational Site Number 840016 | Huntington Park | California | 90255 | — |
| Investigational Site Number 840002 | La Jolla | California | 92037 | — |
| Investigational Site Number 840091 | Los Angeles | California | 90017 | — |
| Investigational Site Number 840058 | Northridge | California | 91324 | — |
| Investigational Site Number 840021 | Palm Springs | California | 92262 | — |
| Investigational Site Number 840087 | Santa Ana | California | 92704 | — |
| Investigational Site Number 840030 | Torrance | California | 90505 | — |
| Investigational Site Number 840065 | Van Nuys | California | 91405 | — |
| Investigational Site Number 840075 | Bradenton | Florida | 34201 | — |
| Investigational Site Number 840076 | New Port Richey | Florida | 34652 | — |
| Investigational Site Number 840026 | Ocoee | Florida | 34761 | — |
| Investigational Site Number 840052 | Palm Harbor | Florida | 34684 | — |
| Investigational Site Number 840080 | Palm Harbor | Florida | 34684 | — |
| Investigational Site Number 840018 | Port Charlotte | Florida | 33952 | — |
| Investigational Site Number 840071 | Lawrenceville | Georgia | 30046 | — |
| Investigational Site Number 840085 | Roswell | Georgia | 30076 | — |
| Investigational Site Number 840072 | Statesboro | Georgia | 30461 | — |
| Investigational Site Number 840039 | Stockbridge | Georgia | 30281 | — |
| Investigational Site Number 840036 | Arlington Heights | Illinois | 60005 | — |
| Investigational Site Number 840010 | Chicago | Illinois | 60616 | — |
| Investigational Site Number 840005 | Avon | Indiana | 46123 | — |
| Investigational Site Number 840063 | Council Bluffs | Iowa | 51501 | — |
| Investigational Site Number 840098 | Des Moines | Iowa | 50134 | — |
| Investigational Site Number 840101 | Des Moines | Iowa | 50314 | — |
| Investigational Site Number 840096 | West Des Moines | Iowa | 50266 | — |
| Investigational Site Number 840061 | Paris | Kentucky | 40361 | — |
| Investigational Site Number 840011 | Hyattsville | Maryland | 20782 | — |
| Investigational Site Number 840001 | Rockville | Maryland | 20852 | — |
| Investigational Site Number 840041 | Flint | Michigan | 48504 | — |
| Investigational Site Number 840057 | Flint | Michigan | 48532 | — |
| Investigational Site Number 840033 | Troy | Michigan | 48085 | — |
| Investigational Site Number 840084 | Olive Branch | Mississippi | 38654 | — |
| Investigational Site Number 840048 | Chesterfield | Missouri | 63017 | — |
| Investigational Site Number 840023 | Las Vegas | Nevada | 89117 | — |
| Investigational Site Number 840045 | Las Vegas | Nevada | 89128 | — |
| Investigational Site Number 840031 | Linden | New Jersey | 07036 | — |
| Investigational Site Number 840060 | Hickory | North Carolina | 28601 | — |
| Investigational Site Number 840064 | Morganton | North Carolina | 28655 | — |
| Investigational Site Number 840043 | Wilmington | North Carolina | 28401 | — |
| Investigational Site Number 840082 | Winston-Salem | North Carolina | 27103 | — |
| Investigational Site Number 840025 | Oklahoma City | Oklahoma | 73104 | — |
| Investigational Site Number 840022 | Oklahoma City | Oklahoma | 73112 | — |
| Investigational Site Number 840029 | Beaver | Pennsylvania | 15009 | — |
| Investigational Site Number 840056 | Downingtown | Pennsylvania | 19335 | — |
| Investigational Site Number 840093 | Anderson | South Carolina | 29621 | — |
| Investigational Site Number 840097 | Greenville | South Carolina | 29605 | — |
| Investigational Site Number 840070 | Greer | South Carolina | 29651 | — |
| Investigational Site Number 840044 | North Myrtle Beach | South Carolina | 29582 | — |
| Investigational Site Number 840069 | Simpsonville | South Carolina | 29681 | — |
| Investigational Site Number 840079 | Bristol | Tennessee | — | — |
| Investigational Site Number 840006 | Chattanooga | Tennessee | 37404 | — |
| Investigational Site Number 840088 | Knoxville | Tennessee | 37912 | — |
| Investigational Site Number 840077 | New Tazewell | Tennessee | 37825 | — |
| Investigational Site Number 840007 | Dallas | Texas | 75230 | — |
| Investigational Site Number 840086 | Dallas | Texas | 75231 | — |
| Investigational Site Number 840027 | Houston | Texas | 77061 | — |
| Investigational Site Number 840004 | Houston | Texas | 77083-4436 | — |
| Investigational Site Number 840040 | Houston | Texas | 77090 | — |
| Investigational Site Number 840046 | Houston | Texas | 77095 | — |
| Investigational Site Number 840054 | Hurst | Texas | 76054 | — |
| Investigational Site Number 840017 | Mesquite | Texas | 75149 | — |
| Investigational Site Number 840008 | Missouri City | Texas | 77459 | — |
| Investigational Site Number 840094 | San Antonio | Texas | 78229-3907 | — |
| Investigational Site Number 840009 | Sugar Land | Texas | 77478 | — |
| Investigational Site Number 840053 | Waco | Texas | 76710 | — |
| Investigational Site Number 840095 | Ogden | Utah | 84405 | — |
| Investigational Site Number 840032 | Salt Lake City | Utah | 84102 | — |
| Investigational Site Number 840024 | Norfolk | Virginia | — | — |
| Investigational Site Number 840020 | Richmond | Virginia | 23219 | — |
| Investigational Site Number 840012 | Renton | Washington | 98055 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 84 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02738151, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 13, 2018 · Synced May 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02738151 live on ClinicalTrials.gov.